Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
PlexusDx's $99 genetic test analyzes GLP1R rs6923761 and GIPR rs1800437 variants, among 150+ insights across 49 peptides, to reveal your innate responsiveness to tirzepatide's dual pathways
This multi-pathway approach to reducing inflammation is far more effective than relying on a single compound, especially in cases of chronic or widespread inflammation
Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL et al
Okun The New England Journal of Medicines recent publication of a randomized study of a GLP-1 agonist originally designed for diabetes, but applied to Parkinson's disease, has led to a flurry of excitement and to a mountain of questions
This may reflect their different antioxidant properties or the limitation in interactions with -tocopherol transport protein at the cellular level
Yet current prescribing guidelines dont recommend asking a basic question before initiating treatment: Does this patient actually have low endogenous GLP-1 levels
US$ 24.89
US$ 21.18
US$ 27.08
US$ 25.20
